KEGG DRUG is a comprehensive drug information resource for approved drugs in Japan, USA and Europe, unified based on the chemical structure and/or the chemical component of active ingredients. Each KEGG DRUG entry is identified by the D number and associated with KEGG original annotations including therapeutic targets, drug metabolism, and other molecular interaction network information.

KEGG DRUG entries are systematically organized in various ways, utilizing both established and KEGG-original classification systems and focusing on specific features such as drug targets and gene variants.

These classification systems are maintained as part of the KEGG BRITE database, so that they can be expanded by combining additional data using the KEGG Mapper Join Brite operation.

Join ATC classification USP drug classification Therapeutic category of drugs Classification of Japanese OTC drugs Risk Category of Japanese OTC drugs and Target Metabolizing enzyme Transporter Structure map

Join New drug approvals in the USA New drug approvals in Europe New drug approvals in Japan New drug approvals in the USA, Europe and Japan and Target Metabolizing enzyme Transporter Structure map

The generic names of drugs can be different in different countries or organizations. The same structure may be called differently and the same name may mean different structures. To accommodate such differences the generic names are associated with the following codes in parentheses.

• JAN - Japanese Approved Name
• USAN - United States Adopted Name
• NF - National Formulary drug name
• INN - International Nonproprietary Name
• BAN - British Approved Name
• DCF - Dénomination commune française

Specifically, for the drugs in Japan and USA whether they are listed in the pharmacopoeia is denoted by:

• JP17 - Japanese Pharmacopoeia, 17th edition
• USP - United States Pharmacopeia

which also imply the JAN and USAN names, respectively. Furthermore, the drugs in Japan include:

• non-JP - Japanese standards for non-Pharmacopoeial crude drugs

for additional crude drugs.

When drug products are available in Japan and/or USA, the following notations are often utilized:

There are three additional databases associated with KEGG DRUG.

KEGG DGROUP contains structurally and functionally related groups of D number entries in KEGG DRUG. Among them chemical groups are used to accommodate minor variations of chemical structures, such as salts and hydration states, especially for identifying essentially the same active ingredients of drugs in different countries.

Drug Interaction Database contains known adverse drug-drug interactions associated with contraindications (CI) and precautions (P) extracted from all the drug labels of Japanese prescription drugs.

• KEGG MEDICUS Drug Interaction Checker

KEGG Drug Structure Maps are part of the KEGG PATHWAY database, graphically illustrating our knowledge of drug development, as many marketed drugs have been developed from lead compounds or existing drugs by introducing chemical structure transformations retaining the core chemical structures.

• KEGG Pathway Maps: Drug Development